Braveheart Bio · 1 month ago
Associate Director, Clinical Operations
Braveheart Bio is a Bay Area–based biopharmaceutical company pioneering best-in-class therapies for cardiovascular disease. The Associate Director, Clinical Operations will be responsible for the execution of clinical trials for the late-stage HCM program, ensuring operational execution and collaboration with various teams to drive trial success.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Support operational planning, start-up, execution, and close-out activities for Phase 3 clinical studies in HCM
Oversee CROs, vendors, clinical sites, and external partners to ensure delivery of high-quality data, adherence to timelines, and compliance with GCP and regulatory requirements
Support development and review of study protocols, operational plans, ICFs, monitoring plans, study manuals, and training materials
Ensure ongoing inspection-readiness across studies, including documentation, processes, and vendor oversight
Identify operational risks proactively and implement mitigation strategies that ensure study continuity and quality
Collaborate with Biometrics, Clinical Pharmacology, and Medical Leads to support data reviews, medical monitoring, and database lock activities
Represent Clinical Operations on cross-functional study teams; provide operational input into development strategy, timelines, and deliverables
Partner with Clinical Development, CMC, Regulatory, and Quality to support cross-functional alignment and regulatory submission readiness
Assist in development of study budgets, forecasting, accrual tracking, and operational metrics
Lead selection, onboarding, and oversight of CROs, central labs, imaging vendors, and specialty service providers
Ensure vendors meet contractual obligations, quality expectations, and KPIs while maintaining transparent communication and issue resolution
Support site engagement strategies, including feasibility, site communications, and escalation management
Ensure clinical trial conduct complies with ICH/GCP, SOPs, and global regulatory expectations
Support SOP development, process improvements, and consistent implementation of best practices across the clinical operations function
Contribute to inspection-readiness activities and support responses to regulatory agency queries as needed
Qualification
Required
Bachelor's degree or higher in a scientific discipline (BS, MS, BSRN, or BS + RN certificate)
Minimum of 8 years of relevant clinical operations experience within biotechnology or pharmaceutical development
Experience leading operational execution for Phase 2 or Phase 3 clinical trials, ideally in cardiovascular, rare disease, or similarly complex indications
Demonstrated success managing CROs and multiple vendors across global studies
Strong understanding of ICH/GCP, clinical trial processes, and regulatory expectations for late-stage development
Proven ability to anticipate operational challenges and implement effective solutions
Strong written and verbal communication skills with a collaborative, team-oriented approach
Ability to thrive in a fast-paced, dynamic environment and remain comfortable with change and ambiguity
Flexible, proactive, and hands-on mindset with a roll-up-your-sleeves, can-do attitude
Preferred
Experience in cardiovascular, heart failure, or HCM clinical trials
Background in a small or emerging biotech with limited infrastructure
Experience supporting NDA/BLA-related operational activities
Familiarity with inspection readiness and agency interactions
Experience with imaging vendors, central labs, and global site networks
Company
Braveheart Bio
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.
Funding
Current Stage
Early StageTotal Funding
$185M2025-11-05Series A· $185M
Recent News
2026-01-06
2025-12-16
Company data provided by crunchbase